Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)
CUSIP: 87978U108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 14,815,636
- Total 13F shares
- 3,067,678
- Share change
- -13,334
- Total reported value
- $3,536,532
- Price per share
- $1.15
- Number of holders
- 13
- Value change
- -$23,290
- Number of buys
- 5
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 87978U108?
CUSIP 87978U108 identifies TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87978U108:
Top shareholders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Versant Vantage II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,118,644
|
$10,127,118 | — | 29 Apr 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
7%
|
1,031,268
|
$1,794,000 | — | 30 Sep 2022 | |
| Rock Springs Capital Management LP |
13F
3/4/5
|
Company · 10%+ Owner |
5.6%
|
823,654
|
$1,433,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
4.4%
|
647,898
|
$1,127,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
240,762
|
$419,000 | — | 30 Sep 2022 | |
| FIL Ltd |
13F
|
Company |
0.87%
|
129,579
|
$225,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.56%
|
82,985
|
$144,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
67,510
|
$117,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
27,000
|
$47,000 | — | 30 Sep 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.08%
|
11,308
|
$20,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
10,964
|
$19,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
4,655
|
$8,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,869
|
$5,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
560
|
$1,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
73
|
$127 | — | 30 Sep 2022 | |
| Pierre Lorenzo |
3/4/5
|
Corporate Controller |
—
class O/S missing
|
8,477
|
— | — | 21 Jun 2022 | |
| Stella Xu |
3/4/5
|
Director |
—
class O/S missing
|
6,635
|
— | — | 01 Jul 2021 | |
| Thomas Woiwode |
3/4/5
|
Director |
—
class O/S missing
|
3,500
|
— | — | 17 Jun 2022 |
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q4 2022
As of 31 Dec 2022,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,067,678 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, FIL Ltd, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, FRANKLIN RESOURCES INC, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
14
Q4 2022 holders
13
Holder diff
-1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.